HCPCS Q0084: Chemotherapy Infusion Administration, Per Visit
HCPCS Level II code Q0084 denotes chemotherapy administration by infusion technique only, billed per visit. This code captures the professional or facility service of delivering chemotherapy via infusion when the drug supply is billed separately. As chemotherapy delivery is a high-cost, high-frequency service across oncology care settings nationally, accurate use of Q0084 affects claims processing, revenue recognition, and quality measurement for infusion services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, common billing practices, and payer coverage considerations. The publication summarizes typical sites of service for infusion administration and highlights where Q0084 is commonly applied relative to drug administration billing.
The report provides benchmarks and comparisons for coverage policies, outlines common modifiers associated with infusion visit billing (listed separately), and reviews implications for claims documentation. It also summarizes policy updates relevant to chemotherapy infusion billing and practical coding considerations for clinicians, coders, and revenue cycle staff. Data not available in the input is noted where applicable.
Sign up for hcpcs Q0084 policy alerts
Get alerted when payer policies referencing Q0084 are released or updated.
Billing Code Overview
HCPCS Level II code Q0084 describes chemotherapy administration by infusion technique only, per visit. This service represents the administration of chemotherapeutic agents via an infusion method without inclusion of the drug product itself.
-
Service type: Chemotherapy administration by infusion
-
Typical site of service: Infusion center or outpatient clinic visit
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with metastatic colorectal cancer presents to an outpatient oncology infusion center for a scheduled chemotherapy infusion visit. The patient arrives after pre-visit nursing assessment confirms current laboratory values acceptable for treatment, intravenous access is established (peripheral IV or implanted port), and antiemetic prophylaxis is given per protocol. The chemotherapy infusion agent was prepared by pharmacy and the visit includes only infusion administration services (no concurrent infusion pump management beyond standard administration, no separate evaluation and management service related to chemotherapy decision-making). The billing for this encounter is reported using Q0084 to indicate chemotherapy administration by infusion technique only, per visit. Typical workflow steps: initial nursing triage and vitals; verification of orders and consent; venous access assessment and catheter flushing; administration of the chemotherapeutic infusion with medication and infusion time documented; post-infusion observation and discharge instructions. Typical site of service is an outpatient infusion center or hospital outpatient department where intravenous chemotherapy is administered.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no modifier applies and payer requires explicit 00 reporting (rare). |
22 | Increased procedural services | Use when administration required substantially greater resources due to complexity (document justification). |
23 | Unusual anesthesia | Use when unusual anesthesia is provided in relation to administration (rare for infusion only). |
52 | Reduced services | Use when the infusion service was partially reduced or not completed as planned. |
53 | Discontinued procedure | Use when the infusion was started but discontinued due to patient complication or intolerance. |
54 | Surgical care only | Not commonly used for infusion-only; included if another provider bills surgical portion separately. |
55 | Postoperative care only | Uncommon for infusion-only encounters; use only if relevant to global surgical billing. |
62 | Two surgeons | Not typical for infusion-only; only if two practitioners are required and both bill. |
78 | Unplanned return to OR | Not applicable to routine infusion; use if patient returned to OR related to complication. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Not typical for infusion-only; include if advanced practitioner role is billed per payer guidance. |
CQ | Service by a nurse practitioner or physician assistant in a facility where PA/NP services are recognized | Use when a recognized mid-level provider performed the infusion service per payer policy. |
QK | Medical direction of two, three, or four concurrent anesthesia procedures | Generally not applicable; included only if anesthesia medical direction is billed. |
QX | Certified nurse-midwife, nurse practitioner, or physician assistant - independent practitioner | Use when a mid-level practitioner independently provided the infusion administration and payer accepts this modifier. |
QY | Medical assistant notice of services of a physician assistant or nurse practitioner | Use where applicable per payer rules to identify services by PA/NP. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207RC0000X | Cancer Surgery (Surgical Oncology) | Surgical oncologists may be involved in port placement and related procedures supporting infusion care. |
207L00000X | Medical Oncology | Medical oncologists direct chemotherapy regimens and supervise infusion services. |
163W00000X | Hematology/Oncology | Hematologist-oncologists manage systemic therapy for hematologic and oncologic malignancies. |
363A00000X | Registered Nurse Anesthetist | Rarely involved; included when anesthesia services are required for infusion-related procedures. |
363L00000X | Nurse Practitioner | NPs commonly perform patient assessment, order verification, and may administer services per state scope. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct | Liver metastases commonly require systemic chemotherapy delivered by infusion. |
C78.01 | Secondary malignant neoplasm of right lung | Pulmonary metastases treated with systemic IV chemotherapy. |
C50.912 | Malignant neoplasm of unspecified site of right female breast | Primary breast cancer frequently managed with IV chemotherapy in outpatient infusion centers. |
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Primary lung cancers often receive systemic IV chemotherapy regimens. |
C61 | Malignant neoplasm of prostate | Advanced prostate cancer may receive systemic chemotherapeutic agents administered by infusion. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
96413 | Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | Commonly billed for short intravenous chemotherapy infusions administered during the visit alongside Q0084 when payer requires CPT-level chemotherapy administration coding. |
96415 | Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary infusion) | Billed when infusion duration extends beyond the initial hour and time-based add-on reporting is applicable. |
96417 | Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (List separately) | Used when multiple sequential infusion drugs are given during the same visit and time-based coding is appropriate. |
96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | Used for non-chemotherapy IV therapeutic infusions administered in the same setting; may be relevant if supportive therapies are given. |
36415 | Collection of venous blood by venipuncture | Often performed pre-infusion for laboratory monitoring required prior to chemotherapy administration. |
36561 | Therapeutic apheresis, for example, plasmapheresis; without replacement of red cells | Occasionally performed in hematologic cases associated with systemic therapy; included when relevant in the same care episode. |